Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Clinical trial NCT04440280 · RECRUITING
Trial details
- NCT number
- NCT04440280
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2026-04-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.